Explore 3 Stock Ideas & Industry Insights Download Free Report

News

This Nasdaq Analytics Stock Jumps 7% Premarket on a Big Earnings Beat

A software-driven analytics company's shares are surging premarket after reporting fiscal second-quarter results that topped Wall Street expectations across both revenue and earnings. Total revenue reached approximately $109 million, up 12% year over year, exceeding the $108.5 million estimate, while adjusted earnings per share …

Nitish Kishor | 09 September 2026

Chime Financial (NASDAQ:CHYM) Jumps 10% Premarket on Stride Bank Acquisition

Chime Financial (NASDAQ:CHYM) shares are trading sharply higher premarket after the company announced a definitive agreement to acquire Stride Bank, N.A. for $590 million in cash, a deal that will convert Chime into a bank holding company and mark its transition from industry challenger …

Nitish Kishor | 09 September 2026

Alphabet (NASDAQ:GOOG) Falls 2% Premarket Despite $15 Billion Finland AI Investment

Alphabet (NASDAQ:GOOG) shares are trading lower premarket even after the company announced plans to invest at least 13 billion euros, approximately $15.1 billion, into AI infrastructure in Finland through 2028, marking the company's largest single investment in Europe. TheCapitalwill be deployed across data centers …

Nitish Kishor | 09 September 2026

Why Is Ingram Micro Holding (NYSE:INGM) Stock Down 6% Premarket?

Ingram Micro Holding (NYSE:INGM) shares are trading lower premarket after majority stockholder Ingram Holdco, an affiliate of Platinum Equity, priced a secondary public offering of 13.125 million shares at $27.25 per share, below the stock's prior closing price of $28.84. The company itself is …

Nitish Kishor | 09 September 2026

InnovAge Holding (NASDAQ:INNV): What's Behind the Stock's 9% Premarket Jump

InnovAge Holding (NASDAQ:INNV) shares are trading sharply higher premarket after the PACE healthcare provider reported fiscal fourth-quarter and full-year 2026 results showing dramaticMarginexpansion and issued strong fiscal 2027 guidance. Full-year revenue grew 15.9% to $989.7 million, while adjusted EBITDA jumped approximately 175% to $94.6 …

Nitish Kishor | 09 September 2026

Intel (NASDAQ:INTC) Falls 2% Premarket After a 9% Rally on Price-Hike Reports

Intel (NASDAQ:INTC) shares are trading lower premarket, giving back a portion of Tuesday's roughly 9% rally that followed a report indicating the company plans another price hike of roughly 10% on PC and enterprise CPUs starting in October, reinforcing pricing-power momentum after prior 2026 …

Nitish Kishor | 09 September 2026

Meta Platforms (NASDAQ:META) Jumps 5% Premarket With New Muse AI Agent Rollout

Meta Platforms (NASDAQ:META) shares are surging premarket following the launch of Muse, the company's long-touted AI agent capable of autonomously sending emails, booking travel, and making purchases across apps on a person's behalf. Muse is designed to access a person's apps across categories including …

Nitish Kishor | 09 September 2026

Why Is Neogen (NASDAQ:NEOG) Stock Up 3% Pre-Market?

Neogen (NASDAQ:NEOG) shares are trading sharply higher in pre-market trading, extending recent gains after strong institutional buying activity and improving analyst sentiment. Neogen is a global life sciences company dedicated to protecting the world's foodSupplyand improving animal health, operating through its Food Safety and …

Nitish Kishor | 09 September 2026

This NASDAQ Biotech Stock Falls 16% Pre-Market Despite Reporting Positive Phase 1 Data

A NASDAQ-listed clinical-stage oncology company is trading sharply lower in pre-market trading despite announcing positive updated Phase 1 data for its lead cancer therapy, a reaction that runs counter to what would typically be viewed as encouraging news. Pyxis Oncology (NASDAQ:PYXS) reported that MICVO …

Nitish Kishor | 09 September 2026

Bullish Analyst Ratings Aren't Stopping This NASDAQ Biotech Stock's 27% Pre-Market Plunge

Tyra Biosciences (NASDAQ:TYRA) shares are plunging over 21% in pre-market trading, giving back recent gains that had been tied to optimism around SURF302 trial data expectations in FGFR-driven cancers. Tyra Biosciences is a clinical-stage biopharmaceutical company focused on developing next-generation precision medicines targeting fibroblast …

Nitish Kishor | 09 September 2026
Support

Hi! How can we help you today?

Loading…